UBS Group’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $596 | Sell |
|
|||||
|
2025
Q2 | $61.4K | Buy |
|
|||||
|
2025
Q1 | $21.8K | Sell |
|
|||||
|
2024
Q4 | $51.1K | Buy |
|
|||||
|
2024
Q3 | $5.28K | Buy |
|
|||||
|
2024
Q2 | $2.47K | Hold |
|
|||||
|
2024
Q1 | $2.55K | Hold |
|
|||||
|
2023
Q4 | $2.27K | Sell |
|
|||||
|
2023
Q3 | $201K | Buy |
|
|||||
|
2023
Q2 | $83.5K | Buy |
|
|||||
|
2023
Q1 | $58.7K | Sell |
|
|||||
|
2022
Q4 | $326K | Buy |
|
|||||
|
2022
Q3 | $193K | Buy |
|
|||||
|
2022
Q2 | $173K | Buy |
|
|||||
|
2022
Q1 | $760K | Buy |
|
|||||
|
2021
Q4 | $172K | Sell |
|
|||||
|
2021
Q3 | $644K | Buy |
|
|||||
|
2021
Q2 | $13K | Buy |
|
|||||
|
2021
Q1 | $13K | Sell |
|
|||||
|
2020
Q4 | $5.61M | Buy |
|
|||||
|
2020
Q3 | $461K | Buy |
|